About Genentech
Genentech is a company based in San Francisco (United States) founded in 1976 was acquired by Roche in March 2009. Genentech has completed 5 acquisitions, including Jecure Therapeutics, MyVisionTrack and RQX Pharmaceuticals. Genentech offers products and services including Medicines and Clinical Trials. Genentech operates in a competitive market with competitors including Merck, Roivant Sciences, AbbVie, Gilead and Lilly, among others.
- Headquarter San Francisco, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Genentech, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$404.2 K (USD), Grant
Sep 22, 2023
-
Investors
Roche
& 1 more
-
Employee Count
Not available
-
Investments & Acquisitions
Jecure Therapeutics
& 4 more
-
Acquired by
Roche
(Mar 12, 2009)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Genentech
Genentech offers a comprehensive portfolio of products and services, including Medicines and Clinical Trials.
Treatments for oncology and other diseases
Conducts studies for new therapies and patient support
People of Genentech
Unlock access to complete
Unlock access to complete
Leadership Team
146 people
Software Development Team
120 people
Product Management Team
79 people
Senior Team
63 people
Sales and Marketing
48 people
Data Analysis and Operations Team
44 people
Principal Team
27 people
Legal and Compliance
26 people
Unlock access to complete
Funding Insights of Genentech
Investors in Genentech
Genentech has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Roche and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked | |
|
Pharmaceuticals and diagnostics kits are developed for various diseases.
|
Locked | Locked | Locked |
Investor details for Genentech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Genentech
Genentech has strategically engaged in corporate development activities, having acquired 5 companies. Notable acquisitions include Jecure Therapeutics, MyVisionTrack and RQX Pharmaceuticals.
Investment portfolio details for Genentech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Therapeutics for NASH and liver fibrosis are discovered and developed.
|
Locked | Locked | 2015 | Locked | |
|
Selective estrogen receptor degraders are developed for breast cancer treatment.
|
Locked | Locked | 2013 | Locked | |
|
Novel antibiotics for community and hospital infections are developed.
|
Locked | Locked | 2010 | Locked |
Complete acquisition details for Genentech
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Genentech
Detailed financials for Genentech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Genentech Comparisons
Peer comparison for Genentech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Genentech
Genentech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, Roivant Sciences, AbbVie, Gilead and Lilly, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical products are manufactured and marketed worldwide.
|
|
| Locked | Locked | Locked |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
|
|
| Locked | Locked | Locked |
Biopharmaceutical research and drug development are conducted globally by AbbVie.
|
|
| Locked | Locked | Locked |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
|
|
| Locked | Locked | Locked |
Traditional pharmaceutical medicines are developed for multiple health fields.
|
|
| Locked | Locked | Locked |
Developer of drugs for the treatment of multiple disorders
|
Detailed competitors of Genentech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Genentech
Complete news archive for Genentech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Genentech
Genentech was founded in 1976 and raised its 1st funding round 47 years after it was founded.
Genentech is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Genentech was founded in 1976 in San Francisco, United States, as a biotechnology firm. Research and development efforts are directed toward manufacturing pharmaceutical products across multiple therapeutic areas, including oncology, immunology, neurology, metabolism, infectious diseases, and ophthalmology. Clinical trial information services are also offered to support medical research and development activities in the sector.
Genentech's top competitors include Merck, Roivant Sciences and AbbVie.
Genentech offers Medicines and Clinical Trials.
Genentech has made 5 acquisitions, including Jecure Therapeutics, MyVisionTrack, and RQX Pharmaceuticals.